Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2000
08/03/2000WO2000044904A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044901A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044899A1 Her-2/neu fusion proteins
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044896A1 Internal ribosome entry site (ires), vector containing same and uses thereof
08/03/2000WO2000044895A1 Method and medicament for inhibiting the expression of a defined gene
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044885A1 STREPTOCOCCUS PNEUMONIAE FabG PROTEIN
08/03/2000WO2000044786A1 Novel potassium channels and genes encoding these potassium channels
08/03/2000WO2000044785A1 Gcsf conjugates
08/03/2000WO2000044784A1 Nucleic acid and amino acid sequences
08/03/2000WO2000044783A1 Meg-4 protein
08/03/2000WO2000044782A2 Ewing's tumour antigen, nucleic acid and antibodies
08/03/2000WO2000044781A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
08/03/2000WO2000044780A1 Polypeptide capable of binding to mannose and uses therefor
08/03/2000WO2000044779A1 MurA
08/03/2000WO2000044776A1 Alpha-conotoxin peptides
08/03/2000WO2000044774A2 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000WO2000044773A1 STAPHYLOCOCCUS AUREUS fabG
08/03/2000WO2000044771A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use
08/03/2000WO2000044770A1 Substituted phenethylamine derivatives
08/03/2000WO2000044769A1 Conotoxin peptides
08/03/2000WO2000044766A1 Inhibition of cationic amino acid transporter protein and uses thereof
08/03/2000WO2000044765A1 Mvk
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044714A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
08/03/2000WO2000044413A1 Methods and compositions for healing and repair of articular cartilage
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044408A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000WO2000044404A2 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000WO2000044403A1 Her-2 binding antagonists
08/03/2000WO2000044401A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/03/2000WO2000044400A1 Treatment for diabetes
08/03/2000WO2000044399A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000WO2000044398A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000WO2000044397A2 Growth of inner ear and monoclonal antibody against utricular epithelium
08/03/2000WO2000044396A1 Use of nerve growth factor for therapy of intraocular tissue pathologies
08/03/2000WO2000044395A1 Methods and compositions for modulating fertility
08/03/2000WO2000044394A1 Method of producing elastin, elastin-based materials and tropoelastin materials
08/03/2000WO2000044393A2 Buccal delivery system for proteinaceous medicaments
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044391A2 Plasminogen kringle 4 region fragments and methods of use
08/03/2000WO2000044390A1 Treatment of bladder and gastrointestinal mastocytosis
08/03/2000WO2000044366A2 Therapeutic compositions containing glutathione analogs
08/03/2000WO2000044365A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000WO2000044356A1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044349A1 Non-invasive vaccination through the skin
08/03/2000WO2000044348A2 Materials and methods for making improved micelle compositions
08/03/2000WO2000044335A2 Uridyl peptide antibiotic (upa) derivatives, their synthesis and use
08/03/2000WO2000044306A1 Biodegradable polymeriprotein based coils for intralumenal implants
08/03/2000WO2000027881A3 Human interleukin 10 mutant proteins
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases
08/03/2000WO2000024896A3 Biological material for preparing pharmaceutical compositions for treating mammals
08/03/2000WO2000024415A3 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
08/03/2000WO2000024412A3 Use of vegf-c or vegf-d gene or protein to prevent restenosis
08/03/2000WO2000023587A3 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
08/03/2000WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis
08/03/2000WO2000018921A3 Synthetic peptides having fgf receptor affinity
08/03/2000WO2000017346A3 Hairpin hybridizer molecules for modulation of gene expression
08/03/2000WO2000014251A3 Human transferase proteins
08/03/2000WO2000013701A3 Angiogenically effective unit dose of fgf-2 and method of use
08/03/2000WO2000010593A9 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS
08/03/2000WO2000009675A9 Adenovirus formulations for gene therapy
08/03/2000WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them
08/03/2000WO2000009550A9 Vanadate resistance glycosylation 4 gene
08/03/2000WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
08/03/2000WO2000009018A9 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
08/03/2000WO2000008174A9 β-CASEIN EXPRESSING CONSTRUCTS
08/03/2000WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof
08/03/2000WO2000008050A9 Dna encoding human monocyte-macrophage apolipoprotein b receptor gene and protein
08/03/2000WO2000006731A3 Persephin arf, a protein encoded by unspliced persephin mrna
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006185A3 Methods of using lanreotide, a somatostatin analogue
08/03/2000WO2000005262A9 Uses of igf-i e domain peptides
08/03/2000WO2000005208A9 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
08/03/2000WO2000001823A3 Flt3-l mutants and methods of use
08/03/2000WO2000000617A9 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons
08/03/2000WO1999063975A3 A method for stimulating the immune system
08/03/2000WO1999062941A8 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/03/2000WO1999062561A3 Gene therapy method
08/03/2000WO1999057132A8 Secreted proteins and polynucleotides encoding them
08/03/2000WO1999015130A3 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
08/03/2000DE19903495A1 Ewing-Tumor-Antigen und Nukleinsäure Ewing's tumor antigen and nucleic acid
08/03/2000CA2743116A1 Alpha-conotoxin peptides with a 4/7 motif
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2383486A1 Treatment of bladder and gastrointestinal mastocytosis
08/03/2000CA2368214A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
08/03/2000CA2363565A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000CA2361621A1 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2361271A1 Methods and compositions for modulating fertility
08/03/2000CA2361262A1 Buccal delivery system for proteinaceous medicaments
08/03/2000CA2361260A1 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000CA2361256A1 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens
08/03/2000CA2361239A1 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
1 ... 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 ... 3163